Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.0055
-0.0006
(-9.84%)
At close: April 4 at 5:29:48 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-212,426
-212,426
-189,286
-172,607
-127,033
Investing Cash Flow
--
--
-2,459
-440
-45
Financing Cash Flow
211,272
211,272
161,561
-7,827
301,795
End Cash Position
64,310
64,310
66,118
97,305
278,148
Capital Expenditure
--
--
-2,459
-440
-45
Issuance of Capital Stock
98,830
98,830
195,455
806
342,665
Repayment of Debt
--
--
--
--
-301
Repurchase of Capital Stock
--
--
--
-380
--
Free Cash Flow
-212,426
-212,426
-191,745
-173,047
-127,078
12/31/2021 - 11/23/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VICO.ST Vicore Pharma Holding AB (publ)
6.80
-2.02%
CANTA.ST Cantargia AB (publ)
1.2950
-2.04%
EGTX.ST Egetis Therapeutics AB (publ)
4.0250
-6.50%
KAN.ST Kancera AB (publ)
1.1020
-1.61%
XBRANE.ST Xbrane Biopharma AB (publ)
0.1800
-4.66%
ELIC.ST Elicera Therapeutics AB (publ)
2.9200
-1.02%
ONCO.ST Oncopeptides AB (publ)
1.6660
-2.34%
FLUI.ST Fluicell AB (publ)
11.66
-14.89%
ISOFOL.ST Isofol Medical AB (publ)
1.9580
-5.64%
LIDDS.ST LIDDS AB (publ)
0.0600
+55.44%